Nantong Guangyuan Chemical (revision 58)

Nantong Guangyuan Chemical Co., Ltd. (trading as GGPeps; ggpeps.net) is a peptide supplier based in Nantong, Jiangsu, China, trading under several designations including GGPeps and GYC, operating a distributed warehouse network and with a substantial associated third-party testing record.^[1][2]

The organisation is one of twenty covered on PeptidePedia under Project:Vendor notability. Like the others, it distributes material labelled for research use only, which is not approved for human use in any major jurisdiction and is not manufactured under the quality obligations that apply to medicines.^[3]

This article describes what is verifiable. Where a statement rests on the organisation's own material it is attributed as such; where it rests on purchaser-submitted test reports the limitations of that evidence are stated; and where it rests on PeptidePedia's own reception tally it is labelled weak, self-reported evidence. Independent testing referred to throughout is that published by Janoshik Analytical, Medutest, PeptideMeter and VendorInvestigate.^[4]

The organisation operates from Nantong, Jiangsu, within the Yangtze delta manufacturing belt.^[1] No incorporation year is documented in sources available to this wiki and none is asserted here.

It trades under several designations — a registered chemical-company name and at least two shorter trading names — and purchaser reports use them interchangeably.^[5] The multiplicity is the most practically consequential fact about the organisation for a reader attempting verification, since material discussed under one designation may not obviously be the same organisation as material discussed under another. The article lists all of them in its opening sentence for that reason.

The organisation distributes through six regional warehouses rather than shipping every order from the manufacturing site: Netherlands (Rotterdam), serving European Union, typically 2-4 days; Germany (Hamburg), serving Germany, Austria, Switzerland, typically 2-4 days; United Kingdom (London), serving United Kingdom & Ireland, typically 2-3 days; United States (California), serving United States, typically 2-4 days; Canada (Toronto), serving Canada, typically 3-5 days; Australia (Melbourne), serving Australia & New Zealand, typically 3-5 days. Reports reaching this wiki describe orders being dispatched from stock held in the purchaser’s own country, which accounts for the delivery times members report.

Purchaser reports describe a distributed warehouse arrangement, with orders fulfilled from regional stock as well as from China, and correspondingly variable transit times and customs exposure.^[5] Certificate content in the submitted set has been middling: purity and appearance consistently, water and method inconsistently.^[6]

A warehouse network introduces a documentary question that single-origin shipping does not: material held in a regional warehouse has a storage history between manufacture and dispatch that the certificate does not describe, and a certificate dated at manufacture says nothing about the interval since.^[5]

The catalogue is conventional. The warehouse arrangement, not the range, is what distinguishes the organisation operationally.^[5]

The associated report set is among the larger on the wiki, second only to the Wuhan entity.^[5] Reported area percent figures have mostly clustered in the high nineties with a modest tail below.

The interpretive limits set out at length on Wuhan Wansheng Biotechnology apply here in the same terms and are not restated. One limitation is specific to this organisation: because material may have been held in a regional warehouse for an undocumented interval, a disagreement between a certificate dated at manufacture and a report dated at receipt may reflect elapsed storage rather than the material as manufactured. Nothing in the available documentation permits distinguishing the two.^[5][6]

The PeptidePedia tally records 1,131 self-reported submissions to July 2026 — the second-largest count in this group. Recurring positive themes are delivery speed from regional stock and catalogue availability; recurring complaints concern the multiple trading names, documentation consistency, and uncertainty about how long material had been in storage.^[4] Self-selected; reception rather than quality.^[4]

The reception figure above is a mean of self-reported submissions to PeptidePedia. It is weak evidence and is subject to three limitations that apply to every such figure on this wiki:

• Self-selection. People who submit are not a sample of purchasers. Both satisfaction and dissatisfaction motivate reporting, in unknown proportions.
• It measures reception, not quality. Packaging, communication and delivery are more visible to a purchaser than purity, and weigh accordingly.
• It is not comparable across communities. Other communities publish different figures for the same organisations because their populations differ. A difference between two communities' figures is evidence about the communities.^[4]

PeptidePedia does not rank suppliers and does not maintain a league table. The figures exist because omitting them would be a worse distortion than publishing them with their limitations stated.^[4]

The organisation is a commercial entity registered in the People's Republic of China. Nothing in the available record indicates a manufacturing authorisation, marketing authorisation or pharmacopoeial registration in any jurisdiction, and none should be inferred from a registered business scope, which is a licensing fact and not a quality assurance.^[1]

Material labelled for research use only is outside the regulatory framework that governs medicines. Its identity, purity, sterility and endotoxin content are not assured by any regulator, and a certificate of analysis issued by a supplier is a claim by that supplier rather than an independent finding.^[3][6]

Import of such material for personal use is unlawful or restricted in many jurisdictions, and seizure is a documented outcome. PeptidePedia describes the legal position and does not advise on it.^[3]

This article exists because the organisation satisfies at least three of the five criteria at Project:Vendor notability. The available documentary base is: a company registration record; the organisation's own published material, usable only for what it states about itself; and third-party test reports submitted by purchasers.^[1][2][5]

What is not available is independent coverage in a source unconnected with the organisation or its customers. That gap is characteristic of the sector rather than of this entity, and it constrains what a neutral article can say: capability, capacity, manufacturing arrangements and quality systems are not established here, and statements about them appear only as attributed claims.^[2]

• Visit GGPeps

• Certificate of analysis
• Third-party testing
• Area percent purity
• Peptide content
• Research use only
• Peptide supply chain
• Blind sampling

• Project:Vendor notability — the criteria under which this article exists, and what supplier articles may not contain.
• Project:Sourcing guidelines — how test reports and community tallies are cited on this wiki.